Lori Coburn

April 2, 2026

Study identifies potential noninvasive blood marker for Crohn’s disease activity

One immune cell signaling molecule was increased in active versus inactive Crohn’s disease in both endoscopic and histologic activity assessments, suggesting it could serve as a potential noninvasive marker of disease activity.

By Leigh MacMillan

From left, Qi Liu, PhD, Lori Coburn, MD, Gregor Neuert, PhD, Keith Wilson, MD, Ken Lau, PhD, and Bennett Landman, PhD, are leading VUMC’s contribution to the “gut cell atlas” program funded by the Leona M. and Harry B. Helmsley Charitable Trust.

November 20, 2019

Grant spurs effort to map biology of Crohn’s disease

VUMC has been awarded a three-year, $3 million grant to map — in unprecedented detail — the biology of Crohn’s disease.

By Bill Snyder